Search research articles
Contact Us
Filters
Showing results (141-150 of 185) with videos related to
Page
of 19
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica
|
May 17, 2017
[A Case of Thyroid-Like Follicular Carcinoma of the Kidney]
Katsuhiro Ito, Hiromitsu Negoro, Masashi Kubota, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
March 5, 2019
[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]
Kazuto Imai, Takahiro Inoue, Ryoichi Saito, et al.
Plos One
|
September 19, 2014
The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer
Kenji Nakayama, Takahiro Inoue, Sadanori Sekiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 24, 2018
[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]
Masashi Kubota, Toshinari Yamasaki, Yuki Teramoto, et al.
The Prostate
|
September 3, 2015
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer
Takayuki Goto, Naoki Terada, Takahiro Inoue, et al.
Journal of Cellular Biochemistry
|
November 30, 2012
Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer
John J Kim, Bo Yin, Christhunesa S Christudass, et al.
Scientific Reports
|
March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Cancer Reports (Hoboken, N.J.)
|
February 22, 2023
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models
Takahiro Nagai, Naoki Terada, Masato Fujii, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 27, 2025
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion-Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer
Yusuke Fukiage, Minekatsu Taga, Mahiro Inamura, et al.
Urology
|
June 9, 2026
Usability and Accuracy of a Novel Automatic Bladder Diary Device (Uro-diary Checker)
Yoshinaga Okumura, Yoshie Amaya, Sou Inamura, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 185) with videos related to
Sort By:
Page
of 19
Hinyokika Kiyo. Acta Urologica Japonica
|
May 17, 2017
[A Case of Thyroid-Like Follicular Carcinoma of the Kidney]
Katsuhiro Ito, Hiromitsu Negoro, Masashi Kubota, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
March 5, 2019
[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments]
Kazuto Imai, Takahiro Inoue, Ryoichi Saito, et al.
Plos One
|
September 19, 2014
The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer
Kenji Nakayama, Takahiro Inoue, Sadanori Sekiya, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
April 24, 2018
[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up]
Masashi Kubota, Toshinari Yamasaki, Yuki Teramoto, et al.
The Prostate
|
September 3, 2015
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer
Takayuki Goto, Naoki Terada, Takahiro Inoue, et al.
Journal of Cellular Biochemistry
|
November 30, 2012
Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer
John J Kim, Bo Yin, Christhunesa S Christudass, et al.
Scientific Reports
|
March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
Cancer Reports (Hoboken, N.J.)
|
February 22, 2023
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models
Takahiro Nagai, Naoki Terada, Masato Fujii, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 27, 2025
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion-Targeted Biopsy Improves the Diagnostic Efficacy of Overall and Clinically Significant Prostate Cancer
Yusuke Fukiage, Minekatsu Taga, Mahiro Inamura, et al.
Urology
|
June 9, 2026
Usability and Accuracy of a Novel Automatic Bladder Diary Device (Uro-diary Checker)
Yoshinaga Okumura, Yoshie Amaya, Sou Inamura, et al.
Page
of 19